Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its wide range of generic and branded drugs, has been facing challenges in recent years. Sources close to the deal suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decision is foreseen in th